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mTI~ODUCTIOI~. 
The previous paper (1) dealt with the properties of a mouse-virulent 
strain (Thomas)  1 of Pneumococcus, which is imr~unologically related 
to,  but not identical with typical  Type HI pneumococci.  One of 
its most prominent properties is its antigenic effectiveness in rabbits. 
In contrast to the rarity of a detectable type-specific (anti-S) 2  response 
on injection of typical Type IH strains, immunization with the Thomas 
strain invariably yielded high titres of anti-Thomas antibodies and 
usually also yielded measurable amounts of antibodies specifically' 
reactive with Type HI pneumococci.  These differences between the 
* Miss Harris' cooperation  in this work was made possible by a  grant from 
The Henry Strong Denison Medical Foundation. 
1 The terms "Thomas" strain and "anti-Thomas  'i serum are employed,  as in 
the preceding paper, to refer to the "non-typical" strain and its antiserum. 
The distinctions  between the antis antibody and the anti-P antibody in the 
serological reactions  of Type IH pneum0cocci have been pointed out in detail by 
TiUett (3).  As stated in the preceding paper, the immunity systems involved in 
the reactions  of anti-Thomas serum with typical Type HI pneumococci are the 
same or similar to the S-anti-S systems involved in the type-specific reactions  of 
the "fixed"  types with their homologous antisera.  The anti-Thomas serum  is 
just as devoid of effect upon Types I  and II pneumococci  as is anti-Type III 
serum  , and the Thomas bacteria are just as little affected by anti-Type I or anti- 
Type II serum as are typical Type III pneumococci. 
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response of rabbits to the Thomas strain and their response to typical 
Type III strains seem to  be important, especially in regard to  the 
anti-Type III response elicited by injection of the Thomas strain. 
It has been general experience (2), not only with rabbits but also 
width larger animals, that potent anti-Type III immune sera are more 
difficult to obtain than are potent anti-Type I  and anti-Type II im- 
mune sera.  The question arises, therefore, whether the antigen which 
gives rise to the Type III anti-S antibody is intrinsically a less effec- 
tive antigen in all animals, or whether this antigen which seems to be 
so ineffective might not in other animals elicit responses comparable 
to those invoked by other types of pneumococcus anti-S antigens. 
As a  step in the accumulation of data on this question, we have 
compared the antibody response invoked in rabbits with that invoked 
in mice when the two species of animals are immunized with typical 
Type III pneumococci and with  the  related, but different, Thomas 
strain.  The measurements of the immunity response have included 
antibodies reactive with the Thomas strain as well as those reactive 
with typical Type III strains, for anti-Type III horse serum and anti- 
Thomas rabbit serum usually contain antibodies reactive with both 
kinds of pneumococci (Thomas and Type III). 
EXPEI~ n~rENTAL. 
Comparison of the Antibody Response of Rabbits to Immunization with 
Typical Type III Pneumococci  with their Response to Immuni- 
zation with  the  Thomas Strain  When the  Amounts  of 
Bacterial Antigen Are Equal. 
The fact that rabbits respond poorly to Type III pneumococci is 
clearly shown in Tillett's (3)  extensive study in which 18 out of 28 
rabbits  failed to produce in  their serum even the small amount of 
type-specific antibody detectable by  the  delicate mouse protection 
test.  That the Thomas strain is more effective is evident from the 
results of the preceding investigation (1) in which, in addition to the 
uniformly high degree of anti-Thomas potency in all sera, only 1 out 
of 10 rabbits failed to produce the small amount of antibody required 
to  specifically protect mice against virulent Type III pneumococci. 
These facts strongly suggest that the Thomas bacteria are more effec- HARRIS,  SUGG,  AND  NEILL  935 
tive  in  invoking  an  anti-Type  III  response  in  rabbits  than  are  the 
typical Type III bacteria themselves.  It seemed desirable,  however, 
TABLE  I. 
Comparison of the Response of Rabbits to the Injection of Typical Type III Pneu- 
mococci with the Response to Equal Amounts of the Thomas Strain. 
Immune serum  Anti-Type In potency 
Agglutination 
Heated broth 
culture 
Serum dilution 
Rabbit  Immunization 
material 
1  Thomas strain 
2  Thomas strain 
3  Typical Type III 
strain 
4  Typical Type III 
strain 
Anti-Type III horse serum 
(control) 
Anti-Type I ,and anti-Type 
II horse serum (controls) 
Concentrated 
suspension  of 
heated bacterial 
cells 
Undilu- 
ted 
+: 
0 
0 
+-~+ 
0 
Serum dilution 
Wn- 
2/5  ]  1/5  dilU-ted 
+  0  fff 
0  0  f 
0  I  o  o 
0  0  0 
[+++  +++  fff 
0  0  0 
l/s 
ff 
0 
0 
0 
It 
0 
Passive protection 
of mice vs. virulent 
Type III culture 
Dose Of culture,  co. 
I 
1X  1X  I1X  1X 
I0-*  10-4 I 10-6 101 
D  S  S  S 
D  D-S ] S  S 
D  D  D  D 
D  D  D  D 
D-S  S  S  S 
D  D  D  D 
+  + +  =  compact disc, with clear superaatant, after 2 hours at 37°C.;  +  +  -- 
compact disc, but supernatant not entirely clear; +  -- definite granulation of the 
bacteria which persists after thorough shaking. 
fff  =  sedimentation of agglutinated particles almost complete within  10 min- 
utes at 25°C.; ff =  sedimentation begun and fluid partially cleared by aggregation 
of agglutinated particles; f  =  definite granulation of the bacteria but fluid not 
cleared by aggregation. 
D  =  mice died within 72 hours in all tests; D-S  -- protection irregular, mice 
dying in some tests and surviving in others; S  =  mice survived in all tests.  Viru- 
lence controls died within 72 hours when injected with 1  ×  10  -8 cc. of culture. 
that  a  comparison be made by  experiments  in which the  amount  of 
bacterial antigen and the number of injections were exactly the same. 
Two rabbits  were immunized against  typical Type III pneumococci by two 
courses of six daily injections of heat-killed bacterial suspension equivalent to 5 cc. 936  PhTEU}~OCOCCI.  11 
of broth culture in each dose; a week's rest was given between the first and second 
courses, and the animals were bled 10 days after the last injection.  Two other 
rabbits of the same weight were  immunized with the Thomas strain by the same 
number of injections and with the same amount of bacterial suspension.  A sum- 
mary of the tests of the immune  sera is presented in Table I. 
The results in Table I show that the particular rabbits injected with 
typical Type III pneumococci in  this  experiment failed to  produce 
antibodies reactive with the homologous bacteria,  although both  of 
the  rabbits  immunized  with  the  same  amount  of  the  related  but 
different strain,  produced antibodies reactive with typical Type III 
pneumococci.  While  the  anti-Type  III  potency of  the  anti-Type 
III and anti-Thomas serum as obtained from different immune rab- 
bits will vary, the individual rabbits of each series used in this particu- 
lar experiment yielded serum that can be accepted as possessing about 
the average potency exhibited by Tillett's series of 28 rabbits  and by 
our previous series of 10 rabbits.  Hence, with the above results con- 
sidered as  representative of those  most  likely to  be  obtained  with 
rabbits, it  is evident that  rabbits  can produce antibodies specifically 
reactive with typical Type III pneumococci more readily when  in- 
jected with the Thomas strain than when injected with typical Type 
III pneumococci themsdves.  The  results in Table I  are  important 
as evidence that  this  relation holds true when the amount of total 
bacterial antigen and the conditions of immunization are kept constant. 
Both of the rabbits injected with the Thomas bacteria yielded serum 
potent against the homologous strain, while neither of the anti-Type 
III rabbit sera reacted at all with the Thomas strain.  Since our chief 
interest is in the anti-Type III response, the results of the tests of the 
anti-Thomas potency are not included in Table I. 
Comparison  of the Active Immunity Response  of Mice to  Vaccination 
with Typical Type III Pneumococd with the Response to Vac- 
cination  with the  Thomas  Strain  of Pneumococci. 
The preceding experiment dealt with the  responses of rabbits  to 
immunization with typical Type III pneumococci and to immuniza- 
tion  with the Thomas strain.  The following experiment deals with 
the  responses  of mice to  immunization with these two related but 
different kinds of pneumococci. HAERIS,  SUGG, AND  NEILL  937 
Immunir,  a~ion.--Two series of 60 white mice, about 3 months old, were selected 
for immunization;  one series was injected  with the Thomas strain and the other 
with a typical Type III strain.  The organisms from 10 hour broth cultures were 
resuspended in salt solution and heated at 600C. for 30 minutes.  The suspensions 
of the two kinds of pneumococci were compared and when not approximately equal 
in turbidity, the stronger suspension was diluted  until the concentration  of total 
bacterial substance  in each was about the same.  Each mouse received, subcuta- 
neously, 0.5 cc. of the respective vaccine (Type HI or Thomas), equivalent  to 0.15 
cc. of broth culture, every 2 days for six doses; after which time one dose was given 
intraperitoneally.  10 days after the last injection, 20 mice from each series were 
tested for immunity against the two kinds of pneumococci.  The remainder were 
given a second course of immunization  with freshly prepared vaccine in the same 
doses as in the first course.  After a rest period of 10 days, another lot of the im- 
munized mice was tested for immunity either against the Thomas strain or against 
the typical Type III  strain. 
Tests of Immunity.--The active immunity of the vaccinated mice was tested by 
intraperitoneal  injection  of 0.5 cc. of broth containing  the desired  amount of a 
10 hour broth culture of virulent pneumococci.  Some of the mice vaccinated with 
typical Type III were tested against the Thomas strain and others  against the 
homologous typical Type III strain; the Thomas-vaccinated mice were likewise 
tested against the typical Type III strain as well as against the homologous strain. 
The doses used were 1 X 10 -~ and 1 ×  10 -6 cc. of broth culture.  These doses 
are not unreasonably  small since both cultures  were highly virulent and killed 
mice regularly in doses of 1 ×  10 -s cc.  Moreover, it seemed unwise to overtax 
the active immunity of the mice, especially in the case of Type 'III, in which the 
passive  immunity conferred by immune horse serum is usually overwhelmed by 
doses above 1 X 10 "4 cc.  As a matter of fact, however, the Type III-vaccinated 
mice which had responded  at all, apparently were able  to resist  doses approxi- 
mately equivalent  to those against which Type III horse serum can protect, for 
3 out of 4 vaccinated mice which were tested against 1 ×  10 -4 cc. resisted this large 
dose in a later experiment. 
The tests were made after both one and two courses of vaccinations.  However, 
one course proved as effective as two courses, and since there is no essential differ- 
ence in the tests, the results of the entire expernnent are summarized in Table II. 
Table  II presents  a  summary of the  results  of experiments  upon 
the  active  immunity response  of mice  to  vaccination  with  the  two 
related,  but different, kinds of pneumococci--4.e., a  typical Type III 
strain  and  the  Thomas  strain.  In  a  previous  investigation  (4)  on 
the  active  immunization  of  mice  against  Type  II  pneumococci,  it 
was found that within the zone of reasonably small dosage, the num- 
ber of invading bacteria was a  relatively unimportant factor in  corn- 938  I,l~m~JMOCOCCI.  n 
parison to the factor of the differences in the immunity responses of 
the individual mice.  For this reason, we believe the results of experi- 
ments on the active immunity response of mice can best be analyzed 
upon the basis of the percentage of individuals protected among a 
large group of vaccinated mice. 
In the analysis of Table II, it is best to consider first the response of 
the mice as indicated by their immunity against the same strain as 
that with which they were vaccinated.  It is evident that the mice 
vaccinated with Type III pneumococci responded fairly well in re- 
spect to the development of an immunity affording homologous pro- 
tection, for 75 per cent of the 20 animals tested survived the injection 
TABLE  II. 
Summary of Tests of the Response of Mice to Immunization with the Typical Type II1 
Strain and with the Thomas Strain as Evidenced by Their Active Immunity 
against Virulent Cultures of These Two Kinds of Pneumococci. 
Vaccinated mice 
Number  tested .............. 
Number  protected ........... 
Percentage of protection ...... 
Mice vaccinated with typ:cal 
Type III pneumococcl 
Homologous  Heterologous 
protection  protection 
(vs. 1 X  10-  s  (vs. 1 X  10-s 
orl  X10-~cc.  orl  X  10-6cc. 
of virulent  of virulent 
Type III  Thomas 
culture)  culture) 
20  15 
15  0 
75  0 
Mice vaccinated with Thomas 
strain of pneurnococci 
Homologous 
protection 
(vs. 1 X  10-~ 
orl  X  10Scc. 
of virulent 
Thomas 
culture) 
22 
9 
40 
Heterolosous 
protechon 
I  (vs.  1 X  10-~ 
]  or 1 X  10--6  cc. 
of  virulent 
Type Ill 
culture) 
15 
0 
0 
of virulent Type III bacteria.  The response of the mice to the Thomas 
vaccination  was apparently somewhat less effective, for only 40  per 
cent of the  animals tested survived the  injection of the  Thomas or 
homologous bacteria.  Thus, it is evident  that from the standpoint 
of  the  development of  immunity against  the  homologous kind  of 
pneumococci, mice differ from rabbits in respect to the relative effec- 
tiveness of the typical Type III  antigen  and the Thomas antigen. 
Rabbits  almost  invariably  respond  well  to  the  Thomas  strain  by 
producing immune sera of a  high degree of potency, comparable  in 
all respects to that elicited by Type II pneumococci, while an effec- 
tive response of rabbits to the typical Type III antigen is the excep- HARRIS,  SUGG, AND  NEILL  939 
tion  rather  than  the  rule.  The  important  fact  in  regard  to  the 
homologous protection in Table II is not that the mice do not respond 
uniformly well to  the  Thomas vaccination,  but  rather  that  such a 
large percentage of the mice are effectively protected by the Type III 
vaccination.  The percentage of homologous protection exhibited by 
the Thomas-vaccinated group is just  as high  as that obtained in  a 
previous investigation  with  Type II  pneumococci, in  which only 30 
to 40 per cent of a large number of mice were effectively protected by 
homologous vaccination by the procedure employed in  the present 
study.  Thus, it appears that in respect to the development of homol- 
ogous protection,  mice respond just as well, and even better, to the 
Type III  antigen than they do to  two other kinds of pneumococci 
which in rabbits invoke incomparably better responses than do Type 
III pneumococci. 
The response of the mice as evidenced by their immunity against 
the heterologous strain is less important, although it is interesting to 
observe  that  the  mice  failed  to  develop  any detectable  immunity 
against  the  related  strain.  If  the  mice had  been  more uniformly 
protected against the homologous strain, the lack of immunity against 
the heterologous strain would be important, for Type III immuniza- 
tion of horses does give antibodies reactive with the Thomas strain, 
and Thomas immunization of rabbits usually gives antibodies reac- 
tive with typical Type III strains. 
Immunity  Response of Mice  as Evidenced by Passive Protection 
Experiments. 
Since active immunity is not always the same as passive immunity, 
it  seemed important to determine whether or not the serum of the 
vaccinated mice could confer passive protection to other mice. 
In order to eliminate the factor of differences  in the individual responses of the 
vaccinated mice, the serum from 8 mice vaccinated with Thomas bacteria was 
pooled and used as the anti-Thomas immune mouse serum; and the serum from 
8 mice vaccinated with the Type III bacteria was used collectively as the anti- 
Type III immune mouse serum.  Passive protection experiments were then made 
by the usual procedure with doses of 1 × 10 -~ and 1 × 10 -8 cc. of culture, the anti- 
Thomas serum being tested against both Thomas and Type III bacteria and the 
anti-Type III serum against both Type III and Thomas bacteria. 940  PNEU'K~OCOCCI.  II 
The results of the passive protection experiments were in all respects 
analogous to  those obtained in  the previously described active im- 
munity tests.  The factor of differences in the individual responses 
of the vaccinated mice was eliminated by pooling the immune serum. 
The  anti-Type  III  immune mouse  serum  gave  passive  protection 
against Type III alone and not against the related Thomas bacteria; 
and  the  anti-Thomas  immune serum  gave  protection  against  the 
Thomas bacteria and not against the typical Type III strain.  The 
immune mouse sera, however, are scarcely comparable in homologous 
potency to the anti-Type III horse serum or the anti-Thomas rabbit 
serum; and hence their lack of heterologous potency is of tess impor- 
tance, for it is common experience that an antiserum of a slight degree 
of homologous  potency is more usually of a higher degree of specificity. 
Tests with a Recently Isolated Strain of Typical Type Ill Pneumococcus 
of Different Origin from the  Type III  Strain  Employed in 
Vaccination of the Mice. 
In  the  preceding experiments, the  mice were  tested  against  the 
same strain of typical Type III pneumococci as that employed in the 
vaccination.  In  the  previous investigation  (1),  the immunological 
relationships  evidenced in  rabbit  and  horse  antisera  between  this 
strain of Type III pneumococci and the Thomas strain were proved 
to hold true for three other strains of Type III pneumococci which 
had been recently isolated in Nashville.  While there was this evi- 
dence in favor of the immunological homogeneity of typical Type III 
strains, it seemed important to repeat the experiments with a  Type 
III strain known to be of different origin from the Rockefeller Strain 
with which the mice had been vaccinated.  A strain of Type III pneu- 
mococci which had been isolated about  10 days previously from a 
patient in  the Vanderbilt University Hospital was utilized for  this 
purpose in  active immunity tests  against mice vaccinated with the 
Rockefeller Type III  strain  and  against  mice vaccinated with  the 
Thomas strain.  Passive protection tests were also made as described 
previously with both anti-Type HI and anti-Thomas immune mouse 
serum. 
The results were exactly the same as those reported for the tests 
with the strain which had been used in vaccination.  The mice vac- HARRIS, SUCG, AND NEILL  941 
cinated with the Rockefeller Type III strain were protected and the 
mice vaccinated with the Thomas strain were not protected against 
the Nashville Type III strain.  Similarly, the immune serum from 
mice vaccinated with the Rockefeller Type III strain did give,  and 
the serum from the mice vaccinated with the Thomas strain did not 
give passive protection to other mice against the Nashville Type Ill 
strain. 
These tests were made against only the one foreign strain and are 
not presented as an argument for the homogeneity of the Type III 
group of pneumococci.  But  the identical results obtained in  these 
experiments together with those in the preceding investigation, prove 
that the failure of reciprocal protection of mice against Type III pneu- 
mococci by active or passive immunization with the Thomas strain, 
mad the failure of reciprocal protection of mice against the Thomas 
strain by active or passive immunization with the Rockefeller typical 
Type III strain, are not phenomena dependent upon the use of pre- 
cisely the same Type III strain in the immunization and subsequent 
immunity tests. 
Virulence of the Thomas Strain and of the Typical Type III Strain for 
Rabbits. 
In view of the marked differences between the relative immunity 
responses of mice and those of rabbits  to  immunization with typical 
Type III strains and the Thomas strain, it is important to record the 
tests of the virulence of these strains for the two species of animals. 
Both the Thomas strain and the typical Type III strain (A 66, Hospi- 
tal of The Rockefeller Institute) were highly virulent for mice, killing 
them regularly when doses of 1  ×  10-* co. of broth culture were in- 
jected; but it has been shown by Tillett (5) that the virulence of Type 
III pneumococci for mice is by no means an index of the virulence of 
the same strains for rabbits. 
Because of the probably marked differences in the natural immunity of different 
individual  rabbits which has been suggested by Tillett,  four rabbits were tested 
with each strain.  The individual doses were 1 ce. intravenously, 5 ee. intra- 
venously, 5 ec. intraperitoneally and 10 cc. intraperitoneaUy.  None of the rabbits 
died even from the largest doses of the typical Type III strain.  Two of the rabbits 
(those injected with 5 cc. and with 10 cc. intraperitoneally) were killed by the 
Thomas strain.  The cultures injected had not been passed through rabbits. 942  PNEUMOCOCCI.  II 
From these results,  it  is  evident that,  although neither strain  is 
highly virulent (at least without exaltation of potential virulence by 
rabbit passage), the Thomas strain is more virulent for rabbits than 
is the typical Type III strain. 
DISCUSSION. 
The preceding experiments have dealt with the relative effective- 
ness of the responses of mice and of rabbits to immunization with a 
typical Type III strain in comparison with their response to immuniza- 
tion  with the  Thomas strain  which is  related to  but  not  identical 
with Type III pneumococcus. 
In  regard  to  the  response  of  rabbits,  the  apparent  relationship 
between the antigenic effectiveness of the two kinds of pneumococci 
was the same as that already described in the preceding paper; but 
the results of the present study are important in that the conditions 
of immunization and the dosage were kept constant in the animals 
injected with the two strains.  From the standpoint of the develop- 
ment of homologous, specific antibodies, the Thomas strain was in- 
comparably more effective; the  anti-Thomas rabbit  sera  having, as 
usual, a high degree of anti-Thomas potency; and the anti-Type III 
rabbit sera being, as is frequently the case, devoid of anti-Type III 
potency.  The greater effectiveness in rabbits of the Thomas antigen 
was also true from the standpoint of anti-Type III potency; and the 
results in this investigation, as in the preceding one, furnish evidence 
that rabbits can produce antibodies specifically reactive with typical 
Type III pneumococci, more readily when injected with the Thomas 
strain than when injected with typical Type III pneumococci them- 
selves. 
With mice, the results were quite different.  In the experiments with 
these animals, it was found that vacdnation with typical Type III 
pneumococci elicited somewhat better immunity responses,--as indi- 
cated by the higher percentage of individuals which were protected,- 
than  did  vaccination  with  the  Thomas  strain.  The  immunity in 
both instances was  limited to  homologous protection, for both  the 
Thomas strain (which in rabbits invoked an anti-Type III response) 
and  the typical Type III  strain  (which in  horses invokes an  anti- 
Thomas response)  failed to invoke an immunity against the related 
but  different kind  of Pneumococcus.  From the  standpoint of the HARRIS, SUGG~ AND NEILL  943 
active immunity exemplified by homologous protection, the typical 
Type III strain  proved not only to be more effective antigenically 
than was the Thomas strain, but also, in comparison with the results 
of a previous study (4), it appeared to be a more effective antigen in 
mice than  are Type II pneumococci,--aithough the latter, like the 
Thomas  pneumococci, almost invariably give better immunity re- 
sponses  in rabbits. 
Thus, the results show that the relative antigenic effectiveness  of 
these two kinds of related pneumococci, is different in different ani- 
mals;  in rabbits,  the  Thomas  strain  is  more  effective than  typical 
Type III; in mice, the typical Type III is better than Thomas.  These 
relationships  furnish  an  example of  the  influence of the  species  of 
animal  upon  the  apparent  effectiveness  of  bacterial  antigens,  for 
while the potential antigenicity is resident in the chemical structure 
of the  antigen,  its  actual  effectiveness  in  practice  is  determined 
by the individual response of the particular animal.  This example 
of the  marked differences in the  selective effectiveness of  the  two 
different antigens is the more interesting in view of the close serological 
relationship of the two kinds of pneumococci utilized as antigens. 
SUMMARY. 
The  paper  reports  an  experimental  comparison  of  the  antibody 
responses of mice and of  rabbits  to immunization with typical Type 
III pneumococci and a  strain related to Type III.  The results as a 
whole show that the relative antigenic effectiveness of these two kinds 
of related pneumococci, is different in different animals.  In rabbits 
the strain related to but not identical with Type III elicits the better 
response; in mice, the typical Type III strain is more effective.  These 
relationships  furnish  an  example of the influence of  the  species  of 
animal upon the effectiveness of even closely related bacterial antigens. 
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